business astrazeneca 
The Guardian M&A
MARCH 19, 2024
Britain’s biggest drugmaker’s latest acquisition will help it to develop new radiotherapy treatments Business live – latest updates Britain’s biggest drugmaker, AstraZeneca, is to buy a Canadian cancer specialist focused on next-generation treatments for $2.4bn (£1.9bn), the latest in a string of acquisitions made to strengthen its portfolio of new (..)
The Guardian M&A
DECEMBER 12, 2023
Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business AstraZeneca is buying its first vaccine company in a $1.1bn deal that will expand the vaccine and immune therapy business it set up during the Covid-19 pandemic.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Law 360 M&A
DECEMBER 12, 2023
An attorney for AstraZeneca told a Delaware vice chancellor Tuesday that clinical stage biopharmaceutical company Viela Bio Inc. failed to show that AstraZeneca had the shares or clout needed to push through a purportedly underpriced $3 billion sale of the business in 2021.
Business Wire M&A
JANUARY 23, 2023
BUSINESS WIRE)--AstraZeneca is commencing today, through a subsidiary, a tender offer to purchase all outstanding shares of CinCor Pharma, Inc. On 9 January 2023, AstraZeneca announced that it had entered into a definitive agreement to acquire CinCor. WILMINGTON, Del.--(BUSINESS Following the successful closing of the
Law 360 M&A
FEBRUARY 13, 2023
An already busy Chancery Court got busier last week after an accident sidelined a vice chancellor, a year-end Chancery decision triggered a flurry of uncertainty about long-ago issued stocks, and shareholders from Visa, AstraZeneca and Baldwin Risk Partners filed new suits.
IVSC
SEPTEMBER 30, 2022
He subsequently joined KPMG and rose to become Managing Partner of the Business Advisory Practice of the firm in India. With over 40 years of experience across different sectors and countries, many enterprises he has counselled are now multibillion-dollar businesses continuing to grow.
Benzinga
SEPTEMBER 15, 2022
Fortune Business Insights™, provide this information in its latest report titled, "Medical Imaging Market Forecast, 2019-2027.". The major oncology drugs market players are AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, and Medtronic plc. Pune, India, Sept.
Expert insights. Personalized for you.
94 
Let's personalize your content